Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Pfizer Inc
Pfizer Inc And Renovis Inc
Pfizer Inc Products Inc
Pfizer Inc Pfizer Products Inc

Pfizer Inc patents (2012 archive)

Recent patent applications related to Pfizer Inc. Pfizer Inc is listed as an Agent/Assignee. Note: Pfizer Inc may have other listings under different names/spellings. We're not affiliated with Pfizer Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "P" | Pfizer Inc-related inventors

Date Pfizer Inc patents (2012 archive) (updated weekly) - BOOKMARK this page
12/27/12Combinations comprising alpha-2-delta ligands
12/27/12Immunogenic lhrh compositions and methods relating thereto
12/27/12Amino-heterocyclic compounds
12/20/12Veterinary compositions
12/20/12Anti-ige vaccines
12/20/12Infectious clones of torque teno virus
12/20/12Oligopeptides and their use for treating infectious diseases
12/20/12Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
12/13/12Methods for treating bone cancer by administering a nerve growth factor antagonist antibody
12/13/12Polymyxin derivates useful as antibacterial agents
12/13/12Amide compounds useful in therapy
12/13/12Topical antiparasitic formulations
12/06/124-methylpyridopyrimidinone compounds
11/29/12Kat ll inhibitors
11/29/12Salts and polymorphs of 8-fluoro-2--1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
11/22/12Imidazo-pyrazoles as gpr119 inhibitors
11/22/12Aminocyclohexanes and aminotetrahydropyrans and related compounds as gamma-secretase modulators
11/15/12Process for forming amorphous atorvastatin
11/08/12Anti-diabetic compounds
11/08/12A method for detecting a malfunctioning egg picker
11/08/12Novel cephalosporins useful as antibacterial agents
10/25/12Substituted acetyl-coa carboxylase inhibitors
10/18/12Cd40 antibody formulation and methods
10/18/12Salt forms of [r-(r*,r*)]-2-(4-flurorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
10/18/12Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
10/11/12N-linked hydroxamic acid derivatives useful as antibacterial agents
10/11/12Crystalline pyrrolo[2,3-d]pyrimidine compounds
10/11/12Pyrrolo[2,3-d]pyrimidine derivatives: their intermediates and synthesis
10/04/12Saponin adjuvant compositions and methods relating thereto
10/04/12Beneficial effects of combination therapy on cholesterol
09/20/124-1bb binding molecules
09/13/12Fluoro-pyridinone derivatives useful as antibacterial agents
09/13/12Spirocyclic isoxazoline derivatives as antiparasitic agents
09/06/12N2-pyrazolospiroketone acetyl-coa carboxylase inhibitors
09/06/12Substituted heteroaryls
09/06/12Replenishing body stores of fat-soluble vitamins a, and d eradicate chronic viral infection
08/30/12Histamine-3 receptor antagonists
08/23/12Cancer treatment
08/23/12Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders
08/23/12Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
08/16/12Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
08/09/12Antibodies to il-6 and their uses
08/09/12Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators
08/09/12Novel n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as pkc kinase inhibitors
08/09/12Glucagon receptor modulators
07/19/12Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
07/05/12Celecoxib compositions
06/28/12Glucagon receptor modulators
06/21/12Novel fused pyridine compounds as casein kinase inhibitors
06/21/12Benzimidazole derivatives
06/21/12Phenanthrenone compounds, compositions and methods
06/07/12Kat ll inhibitors
06/07/12Solid salt forms of a pyrrole substituted 2-indolinone
05/17/12Pyrrolo[2,3-d]pyrimidine compounds
05/10/12Does unit, pack of dose units and inhaler for inhalation of combination of drugs
05/03/12N1/n2-lactam acetyl-coa carboxylase inhibitors
05/03/12In ovo vaccination of campylobacter in avian species
05/03/12Method of producing human igg antibodies with enhanced effector functions
05/03/12Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h, 4h,6h) carbaldehyde derivatives
04/19/12Anti notch-1 antibodies
04/19/12Treatment of pulmonary hypertension
04/19/12Tricyclic compounds, compositions, and methods
04/12/12Dosage forms of apixaban
04/12/12Tricyclic compounds, compositions and methods
03/29/12Isoxazoline oximes as antiparasitic agents
03/15/12Substituted heterocyclic derivatives and their pharmaceutical use and compositions
03/15/12Alpha-2-delta ligands for non-restorative sleep
03/08/12Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid magnesium
03/01/12Gpr 119 modulators
03/01/12Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
02/16/12Control of protein glycosylation and compositions and methods relating thereto
02/16/12(r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
02/09/12Pyrazoline compounds
02/09/12Substituted 2-amino-fused heterocyclic compounds
02/09/12Hydroxy substituted 1h-imidazopyridines and methods
02/02/12Pyrazole derivatives
01/26/12Parapoxvirus vectors
01/26/12Marked bovine viral diarrhea virus vaccines
01/26/124,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses
01/19/12Preparation of pregabalin and related compounds
01/05/12Anti-ctla-4 and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Pfizer Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Pfizer Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by